| scholarly article | Q13442814 |
| P2093 | author name string | Richard L Guerrant | |
| Glynis L Kolling | |||
| Reinaldo B Oriá | |||
| David T Bolick | |||
| Eileen M Barry | |||
| Deiziane V S Costa | |||
| Aldo Ângelo M Lima | |||
| Pedro Henrique Q S Medeiros | |||
| Solanka E Ledwaba | |||
| P2860 | cites work | A tale of two bacterial enteropathogens and one multivalent vaccine | Q92716425 |
| Multiplex real time PCR panels to identify fourteen colonization factors of enterotoxigenic Escherichia coli (ETEC) | Q30252432 | ||
| Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study | Q30275836 | ||
| Importance of heat-labile enterotoxin in colonization of the adult mouse small intestine by human enterotoxigenic Escherichia coli strains | Q34334112 | ||
| Protective Enterotoxigenic Escherichia coli Antigens in a Murine Intranasal Challenge Model | Q35920317 | ||
| Progress and pitfalls in Shigella vaccine research | Q37105553 | ||
| Enterotoxigenic Escherichia coli EtpA mediates adhesion between flagella and host cells | Q37106403 | ||
| EatA, an immunogenic protective antigen of enterotoxigenic Escherichia coli, degrades intestinal mucin. | Q37546427 | ||
| Combination vaccine strategies to prevent enteric infections | Q40135741 | ||
| Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lipopolysaccharide vaccines in animal models. | Q40267400 | ||
| Simple method for purification of enterotoxigenic Escherichia coli fimbriae | Q40905058 | ||
| WHO consultation on ETEC and Shigella burden of disease, Geneva, 6-7th April 2017: Meeting report | Q47722353 | ||
| The Critical Role of Zinc in a New Murine Model of Enterotoxigenic E. coli (ETEC) Diarrhea. | Q52691340 | ||
| Use of quantitative molecular diagnostic methods to assess the aetiology, burden, and clinical characteristics of diarrhoea in children in low-resource settings: a reanalysis of the MAL-ED cohort study | Q57058807 | ||
| Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990-2016 | Q57927103 | ||
| Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge | Q64109788 | ||
| A murine model of diarrhea, growth impairment and metabolic disturbances with Shigella flexneri infection and the role of zinc deficiency. | Q64996406 | ||
| Safety and immunogenicity of CVD 1208S, a live, oral DeltaguaBA Deltasen Deltaset Shigella flexneri 2a vaccine grown on animal-free media | Q81445405 | ||
| Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine | Q84592118 | ||
| Significance of Enterotoxigenic Escherichia coli (ETEC) Heat-Labile Toxin (LT) Enzymatic Subunit Epitopes in LT Enterotoxicity and Immunogenicity | Q88867094 | ||
| Vaccines Against Shigella and Enterotoxigenic Escherichia coli: A summary of the 2018 VASE Conference | Q92261969 | ||
| P921 | main subject | Shigella flexneri | Q1644417 |
| Escherichia coli | Q25419 | ||
| enterotoxigenic Escherichia coli | Q265214 | ||
| P304 | page(s) | 30 | |
| P577 | publication date | 2020-03-27 | |
| P1433 | published in | NPJ Vaccines | Q30275609 |
| P1476 | title | A bivalent vaccine confers immunogenicity and protection against Shigella flexneri and enterotoxigenic Escherichia coli infections in mice | |
| P478 | volume | 5 |
Search more.